The Atherogenic Triad: The Risk Phenotype in the Metabolic Patient
Introduction Atherogenic dyslipidemia (AD) is a complex metabolic condition that is highly prevalent in individuals with obesity, metabolic syndrome, and type 2 diabetes. It is characterized by a specific imbalance: elevated triglyceride (TG) levels, low concentrations of HDL cholesterol (HDL-C), and a qualitative increase in LDL particles, which become smaller and denser (sdLDL). The most […]